All the updated news related to novo nordisk

All the news related to novo nordisk updated in real time

Found 17

fornovo nordisk

Order by:

Weight-loss jabs linked to ‘severe’ stomach problems – study

Using weight-loss jabs such as Ozempic or Wegovy could increase the risk of “severe gastrointestinal problems”, a study has suggested. The jabs, which have been hailed as a “game-changer” in the fight against obesity, were found to heighten the ...

05 Oct 2023 at 16:00

Weight loss jab ‘significantly’ improves blood sugar in diabetics, study finds

Weight-loss jabs can help people with type 2 diabetes control their blood sugar in the long-term, a study has found. Semaglutide, sold under the brand names Wegovy, Ozempic and Rybelsus, has been hailed as a potential “game changer” in ...

02 Oct 2023 at 23:01

Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests

Weight loss jabs can reduce the risk of a heart attack or stroke in obese people with cardiovascular disease by a fifth, researchers claim. Pharmaceutical company Novo Nordisk conducted a five-year study of semaglutide, which is sold ...

08 Aug 2023 at 15:05

Weight loss jabs improve heart failure symptoms in obese patients – study

Weight loss jabs could improve the symptoms of heart failure in obese patients, a new study has found, allowing them to exercise for longer as well as lose weight. US researchers explored the use of semaglutide – which is sold under ...

25 Aug 2023 at 10:15

What is the new wonder weight loss drug?

An appetite-suppressant drug will soon be available on prescription through the NHS. But who will benefit from the weight loss drug, and is it all it is cracked up to be? – What is the drug? Thousands of people will soon be able to ...

08 Mar 2023 at 10:48

Wegovy weight-loss jab to launch in the UK

The weight loss jab Wegovy is being made available in the UK as part of a “controlled and limited launch”. The drug, also known as semaglutide, will be prescribed via specialist NHS weight management services alongside a reduced ...

04 Sept 2023 at 07:01

Diabetes drug recommended to treat obesity on the NHS

The type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS. Mounjaro – also known as tirzepatide and made by Eli Lilly – is a glucagon-like peptide-1 (GLP-1) agonist, a family of ...

04 Jun 2024 at 13:49

City

Wegovy obesity drug sales more than double but set to slow

Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted growth will slow this year. The Danish pharmaceutical company has become one of Europe’s ...

05 Feb 2025 at 09:17

Novo Nordisk reprimanded for allegedly failing to disclose payments

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report payments to healthcare and patient organisations. Novo Nordisk breached clauses under the ...

17 Feb 2025 at 12:46

Virtual services recommended to tackle obesity crisis

A number of virtual platforms – some of which include the ability to prescribe weight loss jabs – have been recommended for NHS use in a bid to tackle obesity, as demand for traditional face-to-face services ...

15 Aug 2023 at 00:01

Wegovy slashes heart disease risk ‘even before people shed weight’

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food cravings and ...

12 May 2025 at 23:01

Pharmacy leaders issue warning over fake weight-loss jabs

Pharmacy leaders have urged people not to buy fake weight-loss jabs online as they said shortages of Ozempic are expected to stretch into next year. The National Pharmacy Association (NPA) warned of a ...

05 Aug 2024 at 00:01

Years
2025

Iconic Media is Ireland's largest independently owned regional newspaper and media group, with an unrivalled audience in print, online and mobile. We have 19 regional newspapers and 21 digital sites.

Iconic Digital Titles

Iconic Print Titles

Letterkenny Live

This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.